Related references
Note: Only part of the references are listed.Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1
Gili G. Halfteck et al.
JOURNAL OF IMMUNOLOGY (2009)
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
Susan Gilfillan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Expression of ligands to NKp46 in benign and malignant melanocytes
Emanuela Cagnano et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells
Yasser M. El-Sherbiny et al.
CANCER RESEARCH (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
Mattias Carlsten et al.
CANCER RESEARCH (2007)
The coincidence of chromosome 15 aberrations and β2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma
A Paschen et al.
CLINICAL CANCER RESEARCH (2006)
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1
R Gazit et al.
NATURE IMMUNOLOGY (2006)
Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor
S Tahara-Hanaoka et al.
BLOOD (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors
B Le Maux Chansac et al.
JOURNAL OF IMMUNOLOGY (2005)
Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias
P Nowbakht et al.
BLOOD (2005)
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells
AG Freud et al.
IMMUNITY (2005)
Spontaneous vitiligo in an animal model for human melanoma:: Role of tumor-specific CD8+ T cells
R Lengagne et al.
CANCER RESEARCH (2004)
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction
R Castriconi et al.
CANCER RESEARCH (2004)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells
T Igarashi et al.
BLOOD (2004)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The genetics of malignant melanoma: Lessons from mouse and man
L Chin
NATURE REVIEWS CANCER (2003)
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2:: a potential new link between adaptive and innate immunity
TA Fehniger et al.
BLOOD (2003)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Pathways to melanoma development: Lessons from the mouse
GJ Walker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Natural killer cell activation in mice and men: different triggers for similar weapons?
F Colucci et al.
NATURE IMMUNOLOGY (2002)
HLA expression in uveal melanoma: There is no rule without some exception
MJ Jager et al.
HUMAN IMMUNOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells
AC Repp et al.
JOURNAL OF IMMUNOLOGY (2000)
In vivo natural killer cell activities revealed by natural killer cell-deficient mice
S Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
MJ Smyth et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
